EUVIMEDEUVIMED entdecken
Crossref

Defining the genome-wide mutagenic impact of APOBEC3 enzymes

Eszter Németh, Rachel A DeWeerd, Abby M Green, Dávid Szüts

Methods in Enzymology · 2025

DOI: 10.1016/bs.mie.2024.12.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Enzymology, 2025. Verfasst von Eszter Németh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary. Hauptthemen laut MEDLINE: Mutagenesis, Neoplasms, Cytidine Deaminase, Cytosine Deaminase. Die Arbeit nennt 39 Literaturangaben. Gefördert von: NCI NIH HHS, U.S. Department of Defense, Nemzeti Kutatási Fejlesztési és Innovációs Hivatal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Somatic mutations drive cancer initiation and tumor evolution. Therefore, the etiology of mutagenesis in cancer is important to preventative and treatment strategies. Somatic mutagenesis in cancer is a multifactorial process and includes both endogenous and exogenous sources of mutations. One recently recognized source of mutagenesis in cancer is the innate immune APOBEC3 family of enzymes, which catalyze cytosine deamination to restrict viral infection but can aberrantly act on the cellular genome, resulting in mutations. Single base substitution (SBS) signatures, or mutational patterns, identified in cancer genomes have demonstrated widespread mutagenesis caused by APOBEC3 enzymes throughout human tumors. To comprehensively define the consequences of APOBEC3 mutagenesis, we developed an experimental pipeline for prospective analysis of genome-wide mutations caused by APOBEC3 activity. This pipeline can be adapted to analyze additional sources of mutagenesis across a spectrum of cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutagenesisNeoplasmsCytidine DeaminaseCytosine DeaminaseHumansAPOBEC DeaminasesMutationGenome, Human

Stichwörter der Autor:innen

APOBEC3Cytosine deaminationMutagenesis assayWhole genome sequencing

Substanzen

APOBEC3 proteins, humanCytidine DeaminaseAPOBEC DeaminasesCytosine Deaminase

Autor:innen und Institutionen

  • Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
  • Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States; Center for Genome Integrity, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United State…
  • Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary. Electronic address: szuts.david@ttk.hu.

Förderung

  • NCI NIH HHS
  • U.S. Department of Defense
  • Nemzeti Kutatási Fejlesztési és Innovációs Hivatal

Zitieren

APA

Németh, E., DeWeerd, R. A., Green, A. M., & Szüts, D. (2025). Defining the genome-wide mutagenic impact of APOBEC3 enzymes. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2024.12.003

Vancouver

Németh E, DeWeerd RA, Green AM, Szüts D. Defining the genome-wide mutagenic impact of APOBEC3 enzymes. Methods in Enzymology. 2025. doi:10.1016/bs.mie.2024.12.003

BibTeX
@article{Nmeth2025,
  author = {Németh, Eszter and DeWeerd, Rachel A and Green, Abby M and Szüts, Dávid},
  title = {Defining the genome-wide mutagenic impact of APOBEC3 enzymes},
  journal = {Methods in Enzymology},
  year = {2025},
  doi = {10.1016/bs.mie.2024.12.003}
}
Kostenlos starten →